EAM Investors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-138,698
| Closed | -$3.36M | – | 256 |
|
|
2025
Q1 | $3.36M | Buy |
138,698
+4,574
| +3% | +$111K | 0.58% | 75 |
|
|
2024
Q4 | $2.8M | Sell |
134,124
-27,125
| -17% | -$566K | 0.4% | 128 |
|
|
2024
Q3 | $3.21M | Buy |
+161,249
| New | +$3.21M | 0.48% | 112 |
|
|
2023
Q1 | – | Sell |
-148,261
| Closed | -$2.76M | – | 277 |
|
|
2022
Q4 | $2.76M | Sell |
148,261
-33,538
| -18% | -$624K | 0.57% | 49 |
|
|
2022
Q3 | $2.33M | Sell |
181,799
-158,143
| -47% | -$2.03M | 0.51% | 72 |
|
|
2022
Q2 | $2.38M | Sell |
339,942
-25,473
| -7% | -$179K | 0.58% | 51 |
|
|
2022
Q1 | $3.03M | Buy |
365,415
+126,344
| +53% | +$1.05M | 0.56% | 47 |
|
|
2021
Q4 | $1.62M | Buy |
+239,071
| New | +$1.62M | 0.27% | 174 |
|
|
2019
Q2 | – | Sell |
-498,844
| Closed | -$2.54M | – | 261 |
|
|
2019
Q1 | $2.54M | Buy |
+498,844
| New | +$2.54M | 0.62% | 40 |
|
|
2018
Q1 | – | Sell |
-790,872
| Closed | -$3.09M | – | 299 |
|
|
2017
Q4 | $3.09M | Buy |
+790,872
| New | +$3.09M | 0.55% | 44 |
|
|
2015
Q4 | – | Sell |
-60,858
| Closed | -$183K | – | 320 |
|
|
2015
Q3 | $183K | Sell |
60,858
-170,193
| -74% | -$512K | 0.03% | 290 |
|
|
2015
Q2 | $954K | Sell |
231,051
-1,125
| -0.5% | -$4.65K | 0.11% | 296 |
|
|
2015
Q1 | $1.01M | Buy |
+232,176
| New | +$1.01M | 0.12% | 301 |
|
|
2013
Q4 | – | Sell |
-446,957
| Closed | -$1.36M | – | 317 |
|
|
2013
Q3 | $1.36M | Buy |
+446,957
| New | +$1.36M | 0.27% | 141 |
|